The law firm of Hissey Kientz, LLP is announcing the launch of its new website, Propecia Side Effects Lawyers. The site will serve as a news and information resource for individuals who may have developed sexual problems after taking Propecia.
Archive for January, 2012
Propecia Sexual Side Effects Website Launched by Hissey Kientz, LLP Law Firm
Published January 31, 2012 News Leave a CommentTags: Propecia and sexual side effects, Propecia attorney, Propecia class action, Propecia lawsuit, Propecia lawyer, Propecia sexual side effects, Propecia side effects, Propecia warning
Persistent Sexual Side Effects of Propecia for Male Pattern Hair Loss
Published January 31, 2012 Health Alert , News Leave a CommentTags: Propecia and impotence, Propecia and sexual side effects, Propecia erectile dysfunction, Propecia sexual side effects, Propecia side effects, Propecia study, Propecia warning, side effects of Propecia
Dr. Michael S. Irwig from George Washington University discusses the long term sexual side effects that have been associated with the use of Propecia.
FDA Warns of Byetta Side Effects Including Pancreatitis
Published January 31, 2012 News , Warning Leave a CommentTags: Byetta and pancreatitis, Byetta pancreatitis, Byetta side effects, Byetta warning, FDA, Food and Drug Administration
Parents file Zoloft birth defects lawsuit after daughter’s death
Published January 27, 2012 News Leave a CommentTags: Zoloft and birth defects, Zoloft attorney, Zoloft Birth Defects, Zoloft lawsuit, Zoloft lawyer, Zoloft pregnant, Zoloft while pregnant
A Missouri family has filed a Zoloft lawsuit after their infant daughter was born with birth defects. The lawsuit alleges that the antidepressant’s manufacturer knew about the increased risk of birth defects in women who take Zoloft during pregnancy, but failed to properly warn patients.
To prescribe or not to prescribe: That is the statin question, experts debate
Published January 27, 2012 Health Alert , News Leave a CommentTags: Crestor side effects, Crestor warning, Lipitor side effects, Lipitor warning, statin side effects, statin warning, Zocor diabetes, Zocor side effects, Zocor warning
Are statins one of the greatest advances since the introduction of antibiotics, capable of preventing cardiovascular disease in a wide range of patients, even healthy ones, or are clinicians relying too heavily on the lipid-lowering medications, using the drugs too frequently in individuals who would be better treated with an overhaul of their diet and exercise habits?
FDA Turns Down Expanded Use of Merck’s Vytorin and Zetia
Published January 25, 2012 News Leave a CommentTags: FDA, Food and Drug Administration, Vytorin, Vytorin and heart attacks, Vytorin and kidney disease, Vytorin and strokes, Zetia, Zetia and heart attacks, Zetia and kidney disease, Zetia and strokes
Merck & Co., the second-biggest U.S. drugmaker, said cholesterol treatments Vytorin and Zetia failed to win approval to prevent heart attacks and strokes in patients with chronic kidney disease. Vytorin is a combination of Zetia and Zocor, or simvastatin, and has been available in generic form since 2006.
FDA dings Hospira for ‘misleading’ ads for blood drug
Published January 25, 2012 News Leave a CommentTags: abdominal surgery, cardiac pumps, FDA, FDA warning, Food and Drug Administration, Hospira, plasma, Voluven
The U.S. Food and Drug Administration has admonished Hospira Inc. for overstating the capabilities of Voluven, a plasma substitute designed to increase patients’ blood volume after surgery or trauma. In an apparent bid to boost sales, Hospira has improperly claimed that Voluven can be used during major abdominal surgery, to prime cardiac pumps and to treat swelling, according to an FDA letter to a Hospira executive.
FDA Warns J&J’s DePuy Orthopaedics Unit On Custom Devices
Published January 19, 2012 Health Alert , News 1 CommentTags: DePuy hip replacement, DePuy joint replacement, DePuy knee replacement, DePuy Orthopaedics, DePuy warning, Johnson & Johnson
Federal regulators warned Johnson & Johnson’s (JNJ) DePuy Orthopaedics unit that several of its hip, knee and joint replacements were improperly marketed, prompting the company to stop offering some products. In a letter dated Dec. 8, the U.S. Food and Drug Administration said some of the medical-device maker’s products lacked valid applications for premarket approval or investigational device exemptions.
SSRIs Boost Risk of Falls in Dementia Patients
Published January 19, 2012 Health Alert , News Leave a CommentTags: antidepressants, Celexa, dementia, Effexor, Lexapro, nursing home, Paxil, SSRIs, Zoloft
Nursing home residents with dementia who use selective serotonin reuptake inhibitors (SSRIs) have an increased risk of having a fall that causes injury compared with those who do not use SSRIs, new research shows. ”Even at low doses, SSRIs are associated with increased risk of an injurious fall in nursing home residents with dementia,” the authors write.
FDA says Johnson & Johnson subsidiary DePuy sold orthopaedic devices without approval
Published January 18, 2012 News Leave a CommentTags: DePuy hip implants, DePuy hip replacements, DePuy Orthopaedics, DePuy warning, FDA, Food and Drug Administration, hip replacement warning, Johnson & Johnson
A Johnson & Johnson subsidiary sold more than a dozen types of components for orthopaedic devices without getting the necessary approval from regulators, the U.S. Food and Drug Administration said in a warning letter released this week. DePuy Orthopaedics Inc., based in Warsaw, Ind., also had a quality system that didn’t comply with all of the FDA’s requirements, according to the warning letter.
